Compound Summary
Compound Information
L-canavanine
Compound Name: | L-canavanine |
Compound CID: | 439202 |
Synonyms: | L-canavanine canavanine 543-38-4 Canavanin 2-Amino-4-(guanidinooxy)butyric acid More... |
Iupac Name: | (2S)-2-amino-4-(diaminomethylideneamino)oxybutanoic acid |
InChI: | InChI=1S/C5H12N4O3/c6-3(4(10)11)1-2-12-9-5(7)8/h3H,1-2,6H2,(H,10,11)(H4,7,8,9)/t3-/m0/s1 |
InChIKey: | FSBIGDSBMBYOPN-VKHMYHEASA-N |
Canonical Smiles: | C(CON=C(N)N)C(C(=O)O)N |
Isomeric Smiles: | C(CON=C(N)N)[C@@H](C(=O)O)N |
Molecular Weight: | 176.17 |
Molecular Formula: | C5H12N4O3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
L-canavanine
Molecular Weight: | 176.17 |
Molecular Formula: | C5H12N4O3 |
Hydrogen Bond Donor Count: | 4 |
Hydrogen Bond Acceptor Count: | 5 |
Rotatable Bond Count: | 5 |
Heavy Atom Count: | 12 |
Complexity: | 178 |
Synonyms
L-canavanine
| L-canavanine | L-canavanine |
|---|---|
L-canavanine |
canavanine |
543-38-4 |
Canavanin |
2-Amino-4-(guanidinooxy)butyric acid |
UNII-3HZV514J4B |
O-((Aminoiminomethyl)amino)-L-homoserine |
O-((Aminoiminomethyl)amino)homoserine |
(L)-CANAVANINE |
(2S)-2-amino-4-(diaminomethylideneamino)oxybutanoic acid |
3HZV514J4B |
CHEMBL443732 |
CHEBI:609827 |
2-azaniumyl-4-(diaminomethylideneamino)oxybutanoate |
GGB |
L-2-AMINO-4-(GUANIDINOOXY)BUTYRIC ACID |
AI3-52153 |
C5H12N4O3 |
HSDB 3471 |
L(+)-Canavanine |
Spectrum_001137 |
Tocris-0673 |
L-Homoserine, O-((aminoiminomethyl)amino)- |
Prestwick3_000609 |
Spectrum2_000800 |
Spectrum3_001206 |
Spectrum4_000783 |
Spectrum5_001884 |
Lopac-C-9758 |
bmse000073 |
Butyric acid, 2-amino-4-(guanidinooxy)-, L- |
Lopac0_000320 |
BSPBio_000518 |
BSPBio_002592 |
KBioGR_001226 |
KBioSS_001617 |
DivK1c_000360 |
O-carbamimidamido-L-homoserine |
SCHEMBL151097 |
SPECTRUM1500833 |
SPBio_000940 |
BPBio1_000570 |
DTXSID5045041 |
HMS501B22 |
KBio1_000360 |
KBio2_001617 |
KBio2_004185 |
KBio2_006753 |
KBio3_002092 |
NINDS_000360 |
HMS1921K08 |
ZINC3869452 |
BDBM50271982 |
BDBM50370459 |
CCG-40178 |
AKOS006240676 |
DB01833 |
SDCCGMLS-0066683.P001 |
SDCCGSBI-0050308.P003 |
IDI1_000360 |
SMP1_000062 |
NCGC00015287-01 |
NCGC00015287-18 |
NCGC00015287-19 |
NCGC00024722-01 |
NCGC00024722-02 |
NCGC00024722-03 |
NCGC00024722-04 |
(2S)-2-amino-4-guanidinooxy-butanoic acid |
(S)-2-Amino-4-(guanidinooxy)butanoic acid |
O-{Amino(imino)methylamino}-L-homoserine |
X6876 |
Butyric acid, 2-amino-4-(guanidinooxy)-, L |
C00308 |
(2S)-2-amino-4-(carbamimidamidooxy)butanoic acid |
L-Alpha-amino-gamma-guanidinooxy-N-butyric acid |
Q418408 |
L-Homoserine, O-((aminoiminomethyl)amino)- (9CI) |
Eur.J.Pharmacol. 269:269; 271:87 (1994) |
UNII-QXB6XSA047 component FSBIGDSBMBYOPN-VKHMYHEASA-N |
(2s)-2-amino-4-(((diaminomethylidene)amino)oxy)butanoic acid |
56C22C33-8657-4884-BE16-CAF24BF61D77 |
L-Canavanine, >=98% (TLC), powder, from Canavalia ensiformis |
Experimental Data
L-canavanine
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 5 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
L-canavanine
Statistics Data
L-canavanine
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 5 | 1 | 1 |
Statistics Data Visualization
L-canavanine
